BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Galmed Pharmaceuticals Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:03 pm Sale |
2022-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD |
BIOTECHNOLOGY VALUE FUND L P | 9,665 6.900% |
-333 (-3.34%) |
Filing |
| 2021-02-12 4:13 pm Sale |
2020-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD |
BIOTECHNOLOGY VALUE FUND L P | 9,998 8.400% |
-182 (-1.79%) |
Filing |